Vaxa Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Vaxa General Information

Description

Developer of cultivation platform designed for sustainable indoor micro-algae cultivation. The company's platform through the combination of sustainable processes and advanced machine learning has created the first bio-secured, indoor, scalable algae production system, enabling aquaculture producers to access year-round production of quality, pathogen-free, fresh algae with a consistent composition.

Contact Information

Website
www.vaxa.life
Formerly Known As
Algaennovation
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Árleynir 8
  • Capital Region
  • Reykjavik, 112
  • Iceland
+354 513
Primary Industry
Aquaculture
Other Industries
Business/Productivity Software
Environmental Services (B2B)
Machinery (B2B)
Vertical(s)
AgTech, Climate Tech, Artificial Intelligence & Machine Learning
Corporate Office
  • Árleynir 8
  • Capital Region
  • Reykjavik, 112
  • Iceland
+354 513

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaxa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 29-Aug-2023 Completed Generating Revenue
2. Later Stage VC 28-Apr-2021 Completed Generating Revenue
1. Accelerator/Incubator 02-Jul-2018 Completed Generating Revenue
To view Vaxa’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Vaxa Patents

  • 49

    Total Documents Applications and Grants

  • Total Patents Families

  • 16

    Granted

  • 20

    Pending

  • Expiring in next 12 mo

Vaxa Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4755865-A1 Biostimulants and enhancement thereof in spirulina Pending 05-Dec-2024
US-20260198543-A1 Bioavailabile vitamin b12 in spirulina products Pending 26-Jan-2023
US-20260083135-A1 Biostimulants and enhancement thereof in spirulina Pending 26-Jan-2023
EP-4460316-A1 Photosynthetically controlled spirulina products with enhanced content and/or bioavailability of unopposed, active vitamin b12 Pending 26-Jan-2023
EP-4460316-A4 Photosynthetically controlled spirulina products with enhanced content and/or bioavailability of unopposed, active vitamin b12 Pending 26-Jan-2023 C12P19/42
To view Vaxa’s complete patent history, request access »

Vaxa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vaxa Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
MG Capital (Japan) Corporate Venture Capital Minority
MOTOYA INVESTMENT ASIA Corporate Venture Capital Minority
Stefnir Asset Manager Minority
DIC Group Corporation Minority
EIT Food Accelerator/Incubator
To view Vaxa’s complete investors history, request access »

Ready to get started?

Request a free trial

Vaxa FAQs

  • When was Vaxa founded?

    Vaxa was founded in 2016.

  • Where is Vaxa headquartered?

    Vaxa is headquartered in Reykjavik, Iceland.

  • What is the size of Vaxa?

    Vaxa has 20 total employees.

  • What industry is Vaxa in?

    Vaxa’s primary industry is Aquaculture.

  • Is Vaxa a private or public company?

    Vaxa is a Private company.

  • What is Vaxa’s current revenue?

    The current revenue for Vaxa is .

  • How much funding has Vaxa raised over time?

    Vaxa has raised $2.89K.

  • Who are Vaxa’s investors?

    MG Capital (Japan), MOTOYA INVESTMENT ASIA, Stefnir, DIC Group, and EIT Food have invested in Vaxa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process